TY  - GEN
AU  - Diao,Guoqing
AU  - Dong,Jun
AU  - Zeng,Donglin
AU  - Ke,Chunlei
AU  - Rong,Alan
AU  - Ibrahim,Joseph G
TI  - Biomarker threshold adaptive designs for survival endpoints
SN  - 1520-5711
PY  - 2019///1025
KW  - Algorithms
KW  - Antineoplastic Agents
KW  - therapeutic use
KW  - Antineoplastic Agents, Immunological
KW  - Biomarkers, Tumor
KW  - genetics
KW  - Biostatistics
KW  - methods
KW  - Clinical Decision-Making
KW  - Clinical Trials, Phase III as Topic
KW  - Computer Simulation
KW  - Data Interpretation, Statistical
KW  - ErbB Receptors
KW  - antagonists & inhibitors
KW  - Head and Neck Neoplasms
KW  - drug therapy
KW  - Humans
KW  - Models, Statistical
KW  - Neoplasms
KW  - PTEN Phosphohydrolase
KW  - Panitumumab
KW  - Patient Selection
KW  - Precision Medicine
KW  - Predictive Value of Tests
KW  - Randomized Controlled Trials as Topic
KW  - Research Design
KW  - statistics & numerical data
KW  - Squamous Cell Carcinoma of Head and Neck
KW  - Survival Analysis
KW  - Time Factors
KW  - Treatment Outcome
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1080/10543406.2018.1434191
ER  -